Gut microbiota-bile acids-glucagon like peptide-1 axis contributes the resistance to high fat diet-induced obesity in mice

J Nutr Biochem. 2023 Jul:117:109358. doi: 10.1016/j.jnutbio.2023.109358. Epub 2023 Apr 20.

Abstract

In human and rodents, some individuals may remain lean even when they are challenged with high calorie intake. Here, we used C57BL/6J mice to establish animal models of high-fat diet (HFD) induced obesity sensitive (DIO) mice and obesity resistant (DIR) mice. In DIR mice, improved metabolic profile through brown adipose tissue (BAT) activation was observed, while plasma unconjugated bile acids (BAs) were decreased together with increased intestine tauro-conjugated BAs (e.g., T-β-MCA). The composition of the gut flora also differs greatly between DIR and DOR. Using fecal microbiota transplants from DIR mice, HFD fed recipient mice exhibited a trend toward reduced adiposity and improved glucose tolerance, showing increased serum tauro-conjugated BAs levels. STC-1 cell experiments confirmed T-β-MCA could activate FXR/TGR5 pathway and induce the production of GLP-1, inhibiting genes that regulate the ceramide synthesis. Our results indicated that the DIR mice exhibited higher energy expenditure by activating BAT thermogenesis, which may be related to altered gut microbiota-bile acids-glucagon like peptide-1 axis.

Keywords: bile acids; brown adipose tissue; diet induced obesity; gut microbiota; obesity resistant; tauro-conjugated bile acids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bile Acids and Salts*
  • Diet, High-Fat / adverse effects
  • Gastrointestinal Microbiome* / physiology
  • Glucagon-Like Peptide 1 / metabolism
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Obesity / metabolism

Substances

  • Bile Acids and Salts
  • Glucagon-Like Peptide 1